It’s an odd time for the federal government to effectively offer its imprimatur for marijuana, as the White House seems to be ...
Reclassifying marijuana from a Schedule I to a Schedule III drug could be beneficial for science but may also be seen as a safety endorsement for heavy use. A 2024 study found that daily or near-daily ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback